These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 7682159

  • 1. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L, Morris CA, Sheehan MC, Charlesworth JA, Pussell BA.
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [Abstract] [Full Text] [Related]

  • 2. Formation of the terminal complement complex on agarose beads: further evidence that vitronectin (complement S-protein) inhibits C9 polymerization.
    Johnson E, Berge V, Høgåsen K.
    Scand J Immunol; 1994 Mar; 39(3):281-5. PubMed ID: 7510414
    [Abstract] [Full Text] [Related]

  • 3. Complement inhibition by human vitronectin involves non-heparin binding domains.
    Sheehan M, Morris CA, Pussell BA, Charlesworth JA.
    Clin Exp Immunol; 1995 Jul; 101(1):136-41. PubMed ID: 7542572
    [Abstract] [Full Text] [Related]

  • 4. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
    Tschopp J, Masson D, Schäfer S, Peitsch M, Preissner KT.
    Biochemistry; 1988 May 31; 27(11):4103-9. PubMed ID: 2458130
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA, Zhao J, Ninomiya H, Sims PJ.
    J Immunol; 1991 Apr 01; 146(7):2345-51. PubMed ID: 1706395
    [Abstract] [Full Text] [Related]

  • 6. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex.
    Su HR.
    Int Arch Allergy Immunol; 1996 Aug 01; 110(4):314-7. PubMed ID: 8768797
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI, Packman CH, Leddy JP.
    J Clin Invest; 1983 Apr 01; 71(4):795-808. PubMed ID: 6403580
    [Abstract] [Full Text] [Related]

  • 8. The killer molecule of complement.
    Müller-Eberhard HJ.
    J Invest Dermatol; 1985 Jul 01; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER, Preissner KT, Müller-Eberhard HJ.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Jul 01; 284():89-96. PubMed ID: 6587746
    [Abstract] [Full Text] [Related]

  • 10. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ.
    Biochem Soc Symp; 1985 Jul 01; 50():235-46. PubMed ID: 2428370
    [Abstract] [Full Text] [Related]

  • 11. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S, Whitlow MB, Nussenzweig V.
    J Immunol; 1994 Feb 15; 152(4):1927-34. PubMed ID: 7509832
    [Abstract] [Full Text] [Related]

  • 12. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T, Meri S.
    J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959
    [Abstract] [Full Text] [Related]

  • 13. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization.
    McDonald JF, Nelsestuen GL.
    Biochemistry; 1997 Jun 17; 36(24):7464-73. PubMed ID: 9200695
    [Abstract] [Full Text] [Related]

  • 14. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J, Chonn A, Hertig S, French LE.
    J Immunol; 1993 Aug 15; 151(4):2159-65. PubMed ID: 8345200
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor.
    Biesecker G.
    J Immunol; 1990 Jul 01; 145(1):209-14. PubMed ID: 1694202
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
    Bhakdi S, Käflein R, Halstensen TS, Hugo F, Preissner KT, Mollnes TE.
    Clin Exp Immunol; 1988 Dec 01; 74(3):459-64. PubMed ID: 2466593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.